Epstein‐Barr virus–associated lymphoepithelial carcinoma after pediatric liver transplant
Adam X. Sang, Aleishia Harris‐Arnold, Neeraja Kambham, Olivia M. Martinez, Sheri M. Krams, Debra Strichartz, Carlos O. Esquivel – 11 April 2016
Adam X. Sang, Aleishia Harris‐Arnold, Neeraja Kambham, Olivia M. Martinez, Sheri M. Krams, Debra Strichartz, Carlos O. Esquivel – 11 April 2016
Pratima Sharma, Neehar D. Parikh, Jessica Yu, Pranab Barman, Brian A. Derstine, Christopher J. Sonnenday, Stewart C. Wang, Grace L. Su – 11 April 2016 – Hepatocellular carcinoma (HCC) is a common indication for liver transplantation (LT). Recent data suggest that body composition features strongly affect post‐LT mortality. We examined the impact of body composition on post‐LT mortality in patients with HCC.
Masood Iqbal, Elgaily A. Elrayah, Oscar Traynor, P. Aiden McCormick – 11 April 2016 – The Irish National Liver Transplant program commenced in 1993 in St. Vincent's University Hospital in Dublin. It is an adult‐only program and is the only liver transplant program in Ireland. Pediatric recipients are referred to King's College Hospital in the United Kingdom. To date, almost 1000 adult liver transplants have been performed. Current 1‐year patient survival is 93%, and 5‐year survival is 79%. The program is fully funded by the government health service.
Vincent Wai‐Sun Wong, Grace Lai‐Hung Wong, Henry Lik‐Yuen Chan – 8 April 2016
Arvinder Soin, Hirak Pahari, Sanjay Goja, Prashant Bhangui, Amit Rastogi – 6 April 2016
Margit Mahlapuu, Hanns‐Ulrich Marschall – 4 April 2016
Michael R. Lucey, John P. Rice – 4 April 2016
Joseph Bloomer – 4 April 2016
Resat Ozaras, Mustafa Sunbul, Mehmet Parlak, Hurrem Bodur, Hakan Leblebicioglu – 4 April 2016
Wan‐Hsin Wen, Chi‐Wen Huang, Wei‐Chu Chie, Chun‐Yan Yeung, Lu‐Lu Zhao, Wen‐Terng Lin, Jia‐Feng Wu, Yen‐Hsuan Ni, Hong‐Yuan Hsu, Mei‐Hwei Chang, Lung‐Huang Lin, Huey‐Ling Chen – 4 April 2016 – Despite immunoprophylaxis, hepatitis B virus (HBV) transmission in highly viremic mothers remains a global health issue. Using quantitative maternal surface antigen (HBsAg) to predict HBV infection in infants has not been investigated. We enrolled 526 mother‐infant pairs with positive maternal HBsAg under current immunoprophylaxis.